📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Intellikine

1.1 - Company Overview

Intellikine Logo

Intellikine

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of discovery and development of orally available small-molecule therapies targeting the PI3K/Akt/mTOR pathway, building a discovery platform to rapidly generate kinase inhibitor drug candidates.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Intellikine

Imvax Logo

Imvax

HQ: United States Website
  • Description: Provider of patient-specific vaccines and immunotherapies for solid tumors, including IGV-001, a personalized treatment for glioblastoma in Phase 2b trials, and preclinical programs IEC-001 (endometrial), IHC-001 (hepatocellular), IUC-001 (urothelial), and IOC-001 (ovarian). Offers the Goldspire platform to capture a tumor’s full antigen signature for developing personalized immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Imvax company profile →
GeminX Pharmaceuticals Logo

GeminX Pharmaceuticals

HQ: Canada Website
  • Description: Provider of novel, targeted cancer therapeutics, dedicated to the discovery, development and commercialization of treatments based on research on the Bcl-2 cell death regulation pathway, including the discovery of GX15-070 (obatoclax), a novel small molecule.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GeminX Pharmaceuticals company profile →
858 Therapeutics Logo

858 Therapeutics

HQ: United States Website
  • Description: Provider of small molecule drug development targeting oncology and immunology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 858 Therapeutics company profile →
Trethera Logo

Trethera

HQ: United States Website
  • Description: Provider of small-molecule therapeutics that control DNA replication and integrity, including TRE-515, an orally bioavailable inhibitor of deoxycytidine kinase (dCK) targeting the nucleotide salvage pathway to treat solid tumors and autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Trethera company profile →
Century Therapeutics Logo

Century Therapeutics

HQ: United States Website
  • Description: Provider of iPSC-derived allogeneic NK and T cell therapies for cancer and autoimmune diseases, including CNTY-101 targeting CD19-positive B-cell lymphomas (Phase 1 ELiPSE-1). Offers CRISPR-MAD7 mediated HDR gene editing, Allo-Evasion technology for immune evasion and repeat dosing, CAR and protein engineering, and common engineered iPSC progenitors to accelerate development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Century Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Intellikine

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Intellikine

2.2 - Growth funds investing in similar companies to Intellikine

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Intellikine

4.2 - Public trading comparable groups for Intellikine

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Intellikine

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Intellikine

What does Intellikine do?

Intellikine is a provider of discovery and development of orally available small-molecule therapies targeting the PI3K/Akt/mTOR pathway, building a discovery platform to rapidly generate kinase inhibitor drug candidates.

Who are Intellikine's competitors?

Intellikine's competitors and similar companies include Imvax, GeminX Pharmaceuticals, 858 Therapeutics, Trethera, and Century Therapeutics.

Where is Intellikine headquartered?

Intellikine is headquartered in United States.

How many employees does Intellikine have?

Intellikine has 1,000 employees 🔒.

When was Intellikine founded?

Intellikine was founded in 2010 🔒.

What sector and industry vertical is Intellikine in?

Intellikine is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Intellikine

Who are the top strategic acquirers in Intellikine's sector and industry

Top strategic M&A buyers and acquirers in Intellikine's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Intellikine?

Top strategic M&A buyers groups and sectors for Intellikine include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Intellikine's sector and industry vertical

Which are the top PE firms investing in Intellikine's sector and industry vertical?

Top PE firms investing in Intellikine's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Intellikine's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Intellikine's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Intellikine's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Intellikine include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Intellikine's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Intellikine?

The key public trading comparables and valuation benchmarks for Intellikine include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Intellikine for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Intellikine with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Intellikine's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Intellikine with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Intellikine's' sector and industry vertical?

Access recent funding rounds and capital raises in Intellikine's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Intellikine